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In this study, we demonstrate that the 7SK small nuclear ribonucleoprotein (snRNP) complex is
recruited to the HIV-1 promoter via newly-synthesized HIV-1 nascent transcripts (short transcripts)
in an hnRNP A1-dependent manner and negatively regulates viral transcript elongation. Our deep-
sequence analysis showed these short transcripts were mainly arrested at approximately +50 to +70
nucleotides from the transcriptional start site in the U1 cells, an HIV-1 latent model. TNF-a treat-
ment promptly disrupted the 7SK snRNP complex on the nascent transcripts and viral elongated
transcripts were increased. This report provides insight into how 7SK snRNP complex is recruited
to HIV-1 promoter in the absence of Tat.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Under antiretroviral therapy (ART), latent infections of HIV-1
are often caused by repression of transcriptional initiation of the
viral genome and elongation of nascent transcripts. A useful clue
in the study of latent infection is the presence of abortive tran-
scripts, approximately 60 nucleotides long, in resting T cells of pa-
tients undergoing ART, even though latently infected T cells may
not produce virions and are difﬁcult to distinguish from uninfected
cells [1,2]. Generally, these observations are not viral-speciﬁc, as
genome-wide studies have suggested that cellular RNA polymerase
II (RNAPII) generates many abortive transcripts [3,4].Transcription of the HIV-1 provirus is characterized by early
Tat-independent and late Tat-dependent phases. In the early Tat-
independent phase, HIV-1 transcription depends upon the
interaction of host transcription factors with cis-regulatory DNA
elements within the viral 50 long terminal repeat (LTR) as well as
the assembly of the transcription apparatus, including RNAPII, on
these sequences. In the steady state, Tat-independent HIV-1 basal
promoter activity is weak, because some host factors, which are re-
ported to function as negative regulators of viral LTRs, are known
to restrict HIV-1 basal promoter activity [5]. One of these host fac-
tors, the 7SK small nuclear ribonucleoprotein complex (snRNP),
functions as a negative regulator of HIV-1 transcription by interact-
ing with the positive elongation factor b (p-TEFb), which is com-
posed of cyclin dependent kinase 9 (CDK9) and Cyclin T1 or
Cyclin T2, to mask RNAPII-directed kinase activity. Main compo-
nents of the 7SK snRNP complex are 7SK snRNA, hexamethylene
bis-acetamide inducible 1 (HEXIM1), La-related protein (LARP7)
and methylphosphate capping enzyme (MePCE). LARP7 is a crucial
component of the 7SK snRNP complex and acts as an integral mol-
ecule in 7SK-mediated negative regulation [6,7]. However the viral
accessory protein, Tat interacts with viral promoter proximal
transactivation responsive element (TAR) RNA element and
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promote elongation of RNAPII. After loss of p-TEFb, the 7SK snRNP
complex is known to release HEXIM1 by changing its conformation
[8]. A previous report showed that 7SK snRNP complex, with or
without Tat, are recruited to the HIV-1 cis regulatory enhancer ele-
ment (SP1) before transcription initiation, although it is unclear
how HIV-1 transcription is selectively negative regulated by the
7SK snRNP complex [9].
Heterogeneous nuclear ribonucleoprotein A1 (HnRNP) A1 is a
known as an RNA-binding protein that associates with pre-mRNA,
and functions in viral and host mRNA splicing or metabolism,
including the splicing machinery involved in Tat expression in
HIV-1 [10,11]. HnRNP A1 shuttles from the nucleus to cytoplasm
and is involved in HIV-1 mRNA transport [12]. HnRNP A1 also plays
a role in stabilizing the 7SK snRNP complex through interacting
with 7SK snRNA lacking p-TEFb and HEXIM1 [8].
In this study, we report that hnRNP A1 facilitates recruitment of
the 7SK snRNP complex to the HIV-1 promoter region through
short viral transcripts generated by promoter-paused RNAPII.
2. Materials and methods
2.1. Plasmid construction and cell culture
A 0.7-kb PCR fragment of the 50 LTR region of the NL43 HIV-1
molecular clone was inserted into a pWLG plasmid [13] to generate
pHIV-LTR-GFP. The region fromthe50 LTR to the splicing acceptor re-
gion (0.9 kb) ofpHIV-LTR-GFPwas inserted into theClaI-BamHImin-
imal promoter region of the pNF-jB-MinP-Luc plasmid to generate
pLTR-Luc-pA (HLpA6),whichhas beenpreviously described in detail
[14]. The transiently transfected shRNA expressing plasmid (pmU6)
produces shRNAs from themouse U6 RNA polymerase III promoter.
Control shGFP and sh-hnRNP A1 transduced U1 derived cells were
generated by stably infecting with pSSSP (SIN type-shRNA express-
ing SV40-puro) retrovirus vectors and puromycin drug selection for
2 weeks. The shRNA sequence used in this study are listed in Supple-
mental Table S1.
2.2. Quantitation of HIV-1 viral production by TNF-a stimulation
U1-derived cells (1  106/24-well plate) were stimulated by
TNF-a (10 ng/ml; R&D Systems), and culture supernatants were
then collected by centrifugation at 0, 0.5, 1, 3, 6, 12, or 24 h after
stimulation. Viral transcript and particle production were moni-
tored by qRT-PCR and HIV-1 p24 antigen ELISA (ZeptoMetrix)
according to the manufacturer’s instructions.
2.3. Antibodies
Antibodies used in the experiments were as follows: HEXIM1
[ab25388] (Abcam); CDK9 [C12F7]; hnRNP A1 [R196] (Cell Signal-
ing Technology); LARP7 [A303-723A] (Bethyl Laboratories); MePCE
[14917-1-AP] (proteintech); CyclinT1 [SC10750]; GAPDH
[SC25778] (Santa Cruz) (BD Transduction Laboratories); b-actin
[013-24553] (Wako).
2.4. Chromatin immunoprecipitation (ChIP) assay
Cells were cross-linked with 1% formaldehyde. The lysates were
then sonicated on ice to shear the DNA into fragments with an aver-
age length of less than 0.5 kb by using ELESTAIN035SD (ELECONSci-
ence. Corp). The lysates were incubated overnight on a rotating
platform at 4 C with the respective antibodies (5 mg each), which
were previously bound to Dynabeads Protein G (Invitrogen). After
washing, theDNAwas puriﬁed andquantiﬁed according to the same
protocol described in the RT-PCR section.2.5. RNA preparation and quantitative RT-PCR
Total RNA was prepared from cells using the Isogen II isolation
kit (Wako). For short transcripts, the small RNA fraction (<200 nt)
was puriﬁed using the same kit. The isolated RNA was treated with
Turbo DNase (Ambion) in accordance with the manufacturer’s
instructions. For long transcripts (>200 nt), cDNA was synthesized
from total RNA by ﬁrst-strand cDNA synthesis using the Prime-
Script RT Master Mix (Takara Bio). Quantitative PCR was performed
with a 7300 Real-Time PCR System (Applied Biosystems) using Pre-
mix Ex Taq (Probe qPCR) or SYBR Premix Ex Taq (Takara Bio). For
short transcripts, cDNA was synthesized using the miScript Re-
verse Transcription Kit (Qiagen). Quantitative PCR was performed
with a 7300 Real-Time PCR System (Applied Biosystems) using Pre-
mix Ex Taq (Probe qPCR; Takara Bio). The elongated transcript was
ampliﬁed as the region between the 50 LTR and splicing donor site.
Threshold values (Ct) were calculated, and all reactions were run in
triplicate. The speciﬁc primer pairs and probes used in this study
are listed in Supplemental Table S1.
2.6. RNA immunoprecipitation (RIP) assay
RIP assays were performed and modiﬁed using the RiboCluster
Proﬁler™/RIP-Assay Kit (MBL), according to the manufacturer’s
instructions. RNA was puriﬁed from the precipitates with Isogen
II (Nippon Gene) reagent. These isolated RNAs were treated with
Turbo DNase (Ambion) in accordance with the manufacturer’s
instructions. The cDNA was synthesized and quantiﬁed according
to the same protocol described in the RT-PCR section.
2.7. Deep-sequence analysis of viral short transcripts
We prepared a small RNA fraction (<200 nt) from U1 cells and
ampliﬁed viral short transcripts. Deep sequencing was performed
using the Illumina GAIIx genome analyzer (Illumina) according to
the manufacturer’s instructions. Generated sequences were
mapped to the reference HIV proviral genomic sequence (HIV-
NL43; GenBank accession No. M19921-2). Sequence data that
met the criteria of a quality value greater than 30 (100000 se-
quences) were analyzed. Only sequences that perfectly matched
the ﬁrst 20 nt (GGU CUC UCU GGU CCA UAG GA) of the reference
HIV genomic sequence were used, and we then analyzed the fol-
lowing sequence of the short transcripts (total 82000 reads). All se-
quence data are deposited at the DNA Databank of Japan (DDBJ)
(http://www.ddbj.nig.ac.jp) (accession number DRA000547).
2.8. Statistical analyses
We performed t test. All statistical tests were two-sided. We
considered P values less than 0.05 to be statistically signiﬁcant.
3. Results
3.1. HnRNP A1-knockdown releases suppression of HIV production in
U1 cells
To elucidate the role of hnRNP A1 in the transcriptional regula-
tion of HIV-1 proviral expression, retroviral vectors mediating
either hnRNP A1 shRNA or control (GFP) shRNA expression vectors
were stably transduced into U1 cells. This cell line harbors 2 copies
of intact latent HIV-1 with defective Tat genes, and are often used
as a cell model of latent HIV-1-infection [15]. The expression level
of hnRNP A1 was reduced in U1 cells transduced with the hnRNP
A1 shRNA vector (Fig. 1A). Interestingly, we found that, when
hnRNP A1 was knocked down, albeit only partially, the basal viral
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control (Fig. 1B and C). Since it has been shown that viral transcrip-
tional initiation and elongation is regulated by host factors, we
thought that hnRNP A1 may play a role in regulation of HIV-1 tran-
scriptional initiation or elongation.
After 96 h TNF-a stimulation, the level of elongated viral tran-
scription was upregulated 8-fold in cells in which hnRNP A1 was
knocked down relative to the control (Fig. 1D). Furthermore, a
p24 ELISA demonstrated that, after TNF-a stimulation, production
of HIV-1 particles from the hnRNP A1 shRNA-transduced U1 cells
was signiﬁcantly increased compared with that of U1 cellsFig. 1. hnRNP A1 negatively regulates viral transcript and viral production. (A) Expressi
vector expressing sh-hnRNP A1 (A1) or control GFP shRNA (Con). (B) Schematic represen
elongated transcript) and arrow ‘‘c’’ (qRT-PCR; short transcript). (C) Expression levels
retroviral vector expressing hnRNP A1 (A1) or control shRNA (Con). Asterisks denote va
Kinetics of HIV-1 transcripts, viral production and p24 protein of U1 cells stably transdu
media and cell lysates were collected by centrifugation at 0, 3, 12, 24, 48, 72, or 96 h after
(D), and p24 gag antigen in supernatants was detected by ELISA in order to quantify HIV
HIV-1 promoter site in hnRNP A1 shRNA- or control (GFP) shRNA-transduced U1 cells. RN
shRNA-transduced U1 cells. TNF-a (10 ng/mL) stimulation (1 h) was performed in TNF-a
(b-actin) and control RNA (GAPDH) in U1 (mock) and U1 derived cells which are stablyexpressing control shRNA (Fig. 1E). In contrast some pTEFb-depen-
dent cellular genes (Myc and Fos) were not affected by knockdown
of hnRNP A1 in U1 cells (Fig. 1C) [16]. Together, these results indi-
cated that hnRNP A1 functions as a negative regulator of proviral
transcription in U1 cells.
3.2. Knockdown of hnRNP A1 releases LARP7 from the HIV-1 promoter
Previous research on HIV-1 transcription has demonstrated that
the 7SK snRNP complex negatively regulates viral elongation. To
elucidate whether this complex may be involved in hnRNP A1-on of hnRNP A1 and GAPDH protein in U1 cells stably transduced with a retroviral
tation of the primer positions in this study. Arrow ‘‘a’’ (ChIP), arrow ‘‘b’’ (qRT-PCR;
of HIV-1 elongated transcripts, Myc, and Fos of U1 cells stably transduced with a
lues determined to be signiﬁcantly different from sh-controls [⁄P < 0.05]. (D and E)
ced with a retroviral vector expressing hnRNP A1 or control shRNA (GFP). Culture
TNF-a (10 ng/mL) stimulation (arrow head). Viral mRNA was quantiﬁed by qRT-PCR
-1 particles (E). (F) ChIP assay of relative HEXIM1 and LARP7 abundance around the
ase treatment was performed before immunoprecipitation in RNase + control (GFP)
+ control U1 shRNA-transduced cells. (G) Expression of 7SK snRNPs, control protein
infected with shRNA against GFP (shCon) or hnRNP A1 (shA1).
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were performed, using lysates of U1 cells stably expressing control
or hnRNP A1 shRNA (Fig. 1F). HEXIM1 and LARP7 were recruited to
the HIV-1 LTR in control shRNA-transduced U1 cells. Interestingly,
LARP7, but not HEXIM1, was depleted from the HIV-1 promoter in
hnRNP A1-knockdown cells, but expression of the 7SK snRNP com-
ponents (HEXIM1, LARP7, MePCE, CycT1, CDK9 and 7SK RNA) was
not changed in U1 cells (Fig. 1G). After TNF-a treatment, recruit-
ment of LARP7 to the HIV-1 LTR was reduced even further,
although recruitment of HEXIM1 remained unchanged (Fig. 1F).
These results implied that LARP7 is most likely recruited to the
HIV-1 promoter in the presence of hnRNP A1 and is released from
the LTR after TNF-a treatment in U1 cells.
To elucidate the effect of negative regulation by hnRNP A1 on
viral transcription in greater detail, 293FT-HLpA6 cells stably
expressing ﬁreﬂy luciferase under the control of the HIV LTR pro-
moter were generated. We then performed ChIP assays, using ly-
sates of the 293FT-HLpA6 cells transiently expressing control or
hnRNP A1 shRNA (Fig. 2A). With knockdown of hnRNP A1, elon-
gated viral transcription from the LTR was increased 1.8-fold rela-
tive to the control (Fig. 2B). Also LARP7, but not HEXIM1, was
depleted from the HIV-1 promoter in 293FT-HLpA6 cells (Figs. 1B
and 2C). Since LARP7 is an integral molecule of the 7SK snRNP
complex and maintains pTEF-b in an inactive state in 7SK snRNP
complex [6,7], LARP7 dissociation was examined to determine
whether it affected HIV-1 transcriptional elongation. After trans-
duction with siRNA directed against LARP7 (Fig. 2D), HIV-1 tran-
scriptional elongation was increased 1.6-fold in parental 293FT-
HLpA6 cells relative to the control (Fig. 2E). Together, these results
indicated that the recruitment of LARP7 to the LTR by hnRNP A1 is
one of the causes for the observed negative regulation of viral
elongation.
To facilitate further examination of the effect of transfection
with hnRNP A1 shRNA on HIV-1 LTR promoter transcription levels,
we performed limiting dilution analysis and selected 10 luciferase-
expressing cellular clones from this parental reporter cell popula-
tion. With knockdown of hnRNP A1, the changes in elongated viral
transcription from the LTR in these clones could be divided into
distinct subgroups based on the levels of viral transcription
(Fig. 2F and G): [1] up-regulated (>2-fold), [2] marginally up-regu-
lated (<2-fold), and [3] unchanged (<1.2-fold). Knockdown of
hnRNP A1 affected viral transcription in one-third of the clones;
we found that the basal transcriptional levels of these up-regulated
clones were lower than those of clones in the unchanged category
(Fig. 2H). These results suggested that hnRNP A1 is involved in the
restriction of viral transcription and its effect is closely related to
the viral integration site.
3.3. HEXIM1 interacts with the HIV-1 trans-acting responsive (TAR)
RNA stem-loop in vivo
Next, we investigated the mechanism by which HEXIM1 and
LARP7 are recruited to the HIV-1 LTR. Previous studies have shown
that HEXIM1 binds tightly to HIV-1 TAR RNA and recruits and
inhibits p-TEFb activity in vitro [17,18]. We observed that the
recruitment of HEXIM1 and LARP7 to the HIV-1 LTR in control cells
was eliminated by treatment with RNase before immunoprecipita-
tion (Fig. 1F). Although this observation was possibly due to cleav-
age of 7SK RNA by RNase treatment, it also suggested that the 7SK
snRNP complex is likely to be present near the HIV-1 promoter, be-
cause of an interaction with the viral TAR RNA stem-loops. In U1
cells, there are few elongated transcripts, and only abortive short
transcripts (about 60 nt long) are detected [2]. To ascertain
whether interaction occurs between the 7SK snRNP complex and
the TAR RNA stem-loop region, we identiﬁed the paused orarrested sites of short viral transcripts in U1 cells by using deep-se-
quence analysis. HIV-1 abortive short transcripts have been sug-
gested to pause at +62U, and stop at +65U and +66U from the
TSS, based on in vitro transcription assays [19]. A small-RNA frac-
tion (<200 nucleotides) was prepared from U1 cells, and the short
viral transcripts were ampliﬁed. The short transcripts were mainly
arrested at approximately +50 to +70 nucleotides from the TSS, but
no ‘‘hot spot’’ of transcriptional pause sites was observed at the
nucleotide level (Fig. 3). We next performed an RNA immunopre-
cipitation (RIP) assay by transiently transducing 293FT cells with
a 62 nt long TAR RNA stem-loop expressing plasmid (pmU6-ST)
and using antibodies directed against HEXIM1 (Fig. 4A and B). As
predicted, the exogenous TAR RNA stem-loop was efﬁciently pre-
cipitated with endogenous HEXIM1, as well as with LARP7 and
TAR RNA-binding protein (TRBP; as a positive control; Fig. 4C).
These data indicated the possibility that the 7SK snRNP complex
is recruited to the HIV-1 LTR via interaction with the TAR RNA
stem-loop in vivo.
3.4. The 7SK snRNP complex is released from short transcripts after
TNF-a stimulation
To examine whether the 7SK snRNP complex is recruited to
endogenous nascent early transcripts and released from transcripts
after TNF-a stimulation, the production kinetics of the abortive
short transcripts were compared with those of elongated viral
transcripts after TNF-a stimulation in U1 cells. The production of
short transcripts increased up to 3 h after TNF-a stimulation and
then decreased moderately (Fig. 4D). In contrast, elongated viral
transcripts gradually increased within the initial 6 h after stimula-
tion, and rapidly increased after 6 h. These results imply that a dy-
namic shift in viral transcription occurred over the 3 h period from
the commencement of transcription.
Next, RIP assays were performed on U1 cell extracts before and
3 h after TNF-a treatment (Fig. 4E). Nascent short viral transcripts
were efﬁciently precipitated with the endogenous 7SK snRNP neg-
ative-regulatory transcriptional complex (inhibitory 7SK snRNP
complex, consisting of HEXIM1, MePCE, LARP7, and cyclin T1) prior
to TNF-a treatment. LARP7 and MePCE were released from short
viral transcripts after TNF-a treatment, but the other components
were not. These observations indicated that the 7SK snRNP com-
plex is promptly recruited to the nascent viral transcripts and
TNF-a treatment disrupted the 7SK snRNP complex on the early
viral transcripts. Our observations were congruent with previous
work that indicated that exogenous stimulation disrupted the
inhibitory 7SK snRNP complex [20]. Interestingly, HEXIM1 interac-
tion with short viral transcripts increased after TNF-a treatment
(Fig. 4E). Taken together with the ChIP assay results showing that
HEXIM1 binds to the HIV-1 promoter throughout TNF-a treatment
(Fig. 1F), these results suggested that HEXIM1 is constantly present
at the HIV promoter via interaction with viral short transcripts in
U1 cells.
4. Discussion
Since hnRNP A1 has multiple functions in cellular and viral RNA
splicing and metabolism [10,21], knockdown of hnRNP A1 would
inﬂuence the expression of cellular factors affecting the regulation
of 7SK snRNP complex recruitment to the HIV-1 promoter region.
Notably, the inhibitory 7SK snRNP complex is disrupted on the
HIV-1 short viral transcripts at 3 h after TNF-a stimulation
(Fig. 4E). In agreement with these observations, knockdown of
LARP7 by RNA interference increased the number of elongated vir-
al transcripts (Fig. 2E). These results showed that LARP7 is one of
the molecules involved in negative regulation of viral expression
Fig. 2. LARP7 is recruited to the HIV-1 promoter in an hnRNP A1-dependent manner. (A) Expression of hnRNP A1 protein and GAPDH protein (loading control) in the HLpA6-
293FT cells after 48-h transient transfection of with LacZ (Con) or hnRNP A1 (A1) shRNA-expressing vector. (B) Expression of HIV-1 elongated mRNA in HLpA6-293FT cells
transiently transfected with hnRNP A1 shRNA (sh hnRNP A1) or LacZ shRNA (sh Con). (C) ChIP assay of relative LARP7 abundance around the HIV-1 promoter site after 48-h
transient transfection of HLpA6-293FT cells with hnRNP A1 shRNA (sh hnRNP A1) or LacZ shRNA (sh control). (D and E) Expression of LARP7 protein and GAPDH protein
(loading control) (D) and HIV-1 elongated mRNA (E) in HLpA6-293FT cells transiently transfected with LARP7 siRNA (siLARP7) or vimentin siRNA (siNC). (F and G) qRT-PCR
analysis of HIV-1 elongated mRNA after 48-h transient transfection of 10 HLpA6-293FT clones with hnRNP A1 shRNA or LacZ shRNA (control). The region expanded in qRT-
PCR is denoted with an arrow in (F). Y-Axis represents ‘‘Relative transcription levels’’ based on the value of control LacZ shRNA transduced HLpA6-293FT clones (G). (H)
Expression levels of HIV-1 transcripts of HLpA6-293FT clones. Y-Axis represents ‘‘Relative transcription levels’’ based on the value of HLpA6-293FT#6. Asterisks denote values
determined to be signiﬁcantly different from si- or sh-controls [⁄P < 0.05, ⁄⁄P < 0.01].
Fig. 3. Pausing sites of HIV-1 short transcripts in U1 cells by deep-sequence
analysis. The 30 end of each sequence is mapped to the HIV-1 mRNA (HIVNL43;
GenBank accession No. M19921-2), and the number of reads at each sequence is
plotted on the Y-axis. TSS; transcriptional start site.
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cruited to the short transcripts in an hnRNP A1-dependent manner.
Our data demonstrates that the 7SK snRNP complex can inter-
act with newly synthesized TAR RNA. In RIP and ChIP assays, HEX-
IM1 maintains interaction with TAR RNA after TNF-a treatment
and is permanently present at the LTR even when there is no nas-
cent viral RNA (Fig. 1F). LARP7 and MePCE are recruited to the viral
TAR RNA; however, these proteins dissociate from short transcripts
after TNF-a treatment and LARP7 moves away from the area of the
LTR (Figs. 1F and 4E). These results indicate that some of the com-
ponents of the 7SK snRNP complex could be recruited indepen-
dently to TAR RNA. Previous work has indicated that exogenous
stimulation disrupts the inhibitory 7SK snRNP complex [20]. In
our results, it is possible that HEXIM1 and LARP7 assemble into
the 7SK snRNP complex on the TAR RNA.
Recently, D’Orso et al. reported that the inhibitory 7SK snRNP
complex is involved in transcriptional regulation by recruitment
Fig. 4. 7SK snRNPs are promptly dissociated from viral short transcript by TNF-a stimulation. (A) A schematic representation of the 62 nt trans-acting responsive (TAR) stem
region (nt +1 to +62) of the HIV-1 short transcript. (B) This ﬁgure pertains to the 62 nt of the TAR stem-loop region of HIV-1 transcripts driven by the mouse pol III-type U6
promoter. (C) pmU6-ST was transiently transfected into 293FT cells and, after 48 h, cells were analyzed by an RIP assay using anti-HEXIM1 antibodies, anti-LARP7 antibodies
and anti-TRBP antibodies. Error bars indicate the S.D. (n = 3). (D) The kinetics of HIV-1 short transcripts and elongated viral transcripts at 0, 1/6, 1/2, 1, 3, 6, 24, and 48 h after
TNF-a stimulation (arrow) in U1 cells. (E) RNA immunoprecipitation assay of relative HEXIM1, LARP7, MePCE and CycT1 abundance on HIV-1 viral short transcripts after TNF-
a stimulation (3 h) in U1 cells. Asterisks denote values determined to be signiﬁcantly different from TNF-a () [⁄P < 0.05]. N.D means "not detected".
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volved in transcriptional regulation [9]. Prior to transcriptional ini-
tiation, the inhibitory p-TEFb-7SK snRNP complex with Tat is
loaded into HIV-1 preinitiation complexes (PICs) in an SP1-depen-
dent manner. In this model, upon transcriptional initiation, the
newly synthesized TAR competes for Tat-P-TEFb with 7SK snRNP
complex, which results in efﬁcient viral elongation. Together, these
observations suggest two independent pathways for the recruit-
ment of 7SK snRNP complex to the HIV-1 promoter region. First,
the 7SK snRNP complex with Tat is recruited prior to transcription
via SP1 and PIC. Second, in our model, 7SK snRNP complex directly
recruits TAR RNA immediately after being synthesized from paused
RNAPII in the absence of Tat. The mechanism of transition from
promoter-proximal pausing into transcriptional elongation with
Tat has previously been demonstrated, whereas we have here
uncovered a novel mechanism of transcriptional insufﬁciency of
basal LTR activity in the absence of Tat. Considering bothmechanisms together, it appears that the 7SK snRNP complex plays
dual roles in transcriptional regulation of the HIV LTR: it is a posi-
tive regulator in the presence of Tat, and a negative regulator in the
absence of Tat. These dual roles of 7SK snRNP complex may con-
tribute to inﬂuencing the fate of transcriptional activation of the
HIV LTR.
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